MED
Medifast·NYSE
--
--(--)
--
--(--)
9.91 / 10
Outperform
Fundamental measurement shows robust quality (9.9/10). Constructive metrics: PB-ROE and Revenue-MV, while concerns exist in Diluted earnings per share (YoY growth rate %) and Total profit (YoY growth rate %). Final assessment: superior.
Analysis Checks(3/10)
Revenue-MV
Value1.17
Score2/3
Weight88.47%
1M Return2.24%
Value1.17
Score2/3
Weight88.47%
1M Return2.24%
Profit-MV
Value0.47
Score1/3
Weight25.24%
1M Return0.63%
Value0.47
Score1/3
Weight25.24%
1M Return0.63%
PB-ROE
Value-0.48
Score3/3
Weight251.20%
1M Return6.77%
Value-0.48
Score3/3
Weight251.20%
1M Return6.77%
Net cash flow from operating activities (YoY growth rate %)
Value-58.74
Score0/3
Weight-107.21%
1M Return-3.53%
Value-58.74
Score0/3
Weight-107.21%
1M Return-3.53%
Diluted earnings per share (YoY growth rate %)
Value-141.67
Score0/3
Weight-80.59%
1M Return-2.81%
Value-141.67
Score0/3
Weight-80.59%
1M Return-2.81%
Net cash flow from operating activities per share (YoY growth rate %)
Value-58.94
Score0/3
Weight-90.26%
1M Return-3.00%
Value-58.94
Score0/3
Weight-90.26%
1M Return-3.00%
Net income-Revenue
Value-0.15
Score1/3
Weight31.17%
1M Return0.88%
Value-0.15
Score1/3
Weight31.17%
1M Return0.88%
Total profit (YoY growth rate %)
Value-70.42
Score0/3
Weight-121.24%
1M Return-4.48%
Value-70.42
Score0/3
Weight-121.24%
1M Return-4.48%
Cash-UP
Value-0.05
Score1/3
Weight-68.32%
1M Return-2.34%
Value-0.05
Score1/3
Weight-68.32%
1M Return-2.34%
Cash-MV
Value0.59
Score2/3
Weight171.54%
1M Return4.35%
Value0.59
Score2/3
Weight171.54%
1M Return4.35%
Revenue-MV
Value1.17
Score2/3
Weight88.47%
1M Return2.24%
Value1.17
Score2/3
Weight88.47%
1M Return2.24%
Net cash flow from operating activities per share (YoY growth rate %)
Value-58.94
Score0/3
Weight-90.26%
1M Return-3.00%
Value-58.94
Score0/3
Weight-90.26%
1M Return-3.00%
Profit-MV
Value0.47
Score1/3
Weight25.24%
1M Return0.63%
Value0.47
Score1/3
Weight25.24%
1M Return0.63%
Net income-Revenue
Value-0.15
Score1/3
Weight31.17%
1M Return0.88%
Value-0.15
Score1/3
Weight31.17%
1M Return0.88%
PB-ROE
Value-0.48
Score3/3
Weight251.20%
1M Return6.77%
Value-0.48
Score3/3
Weight251.20%
1M Return6.77%
Total profit (YoY growth rate %)
Value-70.42
Score0/3
Weight-121.24%
1M Return-4.48%
Value-70.42
Score0/3
Weight-121.24%
1M Return-4.48%
Net cash flow from operating activities (YoY growth rate %)
Value-58.74
Score0/3
Weight-107.21%
1M Return-3.53%
Value-58.74
Score0/3
Weight-107.21%
1M Return-3.53%
Cash-UP
Value-0.05
Score1/3
Weight-68.32%
1M Return-2.34%
Value-0.05
Score1/3
Weight-68.32%
1M Return-2.34%
Diluted earnings per share (YoY growth rate %)
Value-141.67
Score0/3
Weight-80.59%
1M Return-2.81%
Value-141.67
Score0/3
Weight-80.59%
1M Return-2.81%
Cash-MV
Value0.59
Score2/3
Weight171.54%
1M Return4.35%
Value0.59
Score2/3
Weight171.54%
1M Return4.35%
Is MED undervalued or overvalued?
- MED scores 9.91/10 on fundamentals and holds a Discounted valuation at present. Backed by its -0.26% ROE, 0.06% net margin, 34.34 P/E ratio, 0.58 P/B ratio, and -97.01% earnings growth, these metrics solidify its Outperform investment rating.
